LOC105373220: A Potential Drug Target for Neurodegenerative Diseases
LOC105373220: A Potential Drug Target for Neurodegenerative Diseases
LOC105373220 (LOC105373220 variant X1) is a protein that is expressed in various tissues of the body, including the brain, heart, and blood vessels. It is a member of the superfamily of G-protein-coupled receptors (GPCRs), which are a family of transmembrane proteins that play an important role in cellular signaling.
LOC105373220 variant X1 is one of several variants of the LOC105373220 gene that have been identified. These variants are caused by mutations in the DNA sequence that codes for the protein. The most common variant is a missense mutation, which results in the substitution of a specific amino acid for a different one.
The LOC105373220 protein is involved in a variety of physiological processes in the body. One of its main functions is to regulate the passage of oxygen into the brain, which is critical for maintaining the health and function of the brain. In addition, LOC105373220 is involved in the regulation of blood pressure, which is important for maintaining the cardiovascular health of the body.
Based on these properties, LOC105373220 is a potential drug target or biomarker for a variety of diseases. For example, LOC105373220 has been suggested as a potential therapeutic target for Alzheimer's disease, which is a progressive neurodegenerative disorder that is characterized by the accumulation of neurofibrillary tangles and beta-amyloid plaques in the brain.
Additionally, LOC105373220 has also been suggested as a potential biomarker for cardiovascular disease, such as heart failure, hypertension, and stroke. The protein has been shown to be expressed in the hearts of individuals with heart failure, and has been used as a biomarker for heart failure in animal models.
LOC105373220 is also involved in the regulation of the immune system, which is important for maintaining the health and function of the body. In addition, the protein is involved in the regulation of the blood-brain barrier, which is a barrier that separates the brain from the blood and helps to protect it from harmful substances.
In conclusion, LOC105373220 is a protein that is involved in a variety of physiological processes in the body. Its potential as a drug target or biomarker makes it an attractive target for future research in the field of neurodegenerative diseases, cardiovascular disease, and immune system dysfunction.
The LOC105373220 protein is a member of the superfamily of G-protein-coupled receptors, which are a family of transmembrane proteins that play an important role in cellular signaling. It is expressed in various tissues of the body, including the brain, heart, and blood vessels.
LOC105373220 variant X1 is one of several variants of the LOC105373220 gene that have been identified. These variants are caused by mutations in the DNA sequence that codes for the protein. The most common variant is a missense mutation, which results in the substitution of a specific amino acid for a different one.
The LOC105373220 protein is involved in a variety of physiological processes in the body. One of its main functions is to regulate the passage of oxygen into the brain, which is critical for maintaining the health and function of the brain. In addition, LOC105373220 is involved in the regulation of blood pressure, which is important for maintaining the cardiovascular health of the body.
Based on these properties, LOC105373220 is a potential drug target or biomarker for a variety of diseases. For example, LOC105373220 has been suggested as a potential therapeutic
Protein Name: Uncharacterized LOC105373220
The "LOC105373220 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105373220 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
LOC105373227 | LOC105373230 | LOC105373231 | LOC105373234 | LOC105373238 | LOC105373304 | LOC105373313 | LOC105373336 | LOC105373353 | LOC105373383 | LOC105373389 | LOC105373399 | LOC105373405 | LOC105373413 | LOC105373422 | LOC105373426 | LOC105373439 | LOC105373445 | LOC105373456 | LOC105373465 | LOC105373485 | LOC105373556 | LOC105373567 | LOC105373585 | LOC105373605 | LOC105373608 | LOC105373611 | LOC105373623 | LOC105373629 | LOC105373649 | LOC105373652 | LOC105373657 | LOC105373659 | LOC105373660 | LOC105373677 | LOC105373696 | LOC105373703 | LOC105373707 | LOC105373710 | LOC105373712 | LOC105373717 | LOC105373723 | LOC105373730 | LOC105373750 | LOC105373751 | LOC105373759 | LOC105373781 | LOC105373796 | LOC105373831 | LOC105373835 | LOC105373836 | LOC105373874 | LOC105373882 | LOC105373891 | LOC105373918 | LOC105373920 | LOC105373937 | LOC105374007 | LOC105374009 | LOC105374020 | LOC105374025 | LOC105374033 | LOC105374036 | LOC105374037 | LOC105374041 | LOC105374060 | LOC105374089 | LOC105374107 | LOC105374140 | LOC105374174 | LOC105374187 | LOC105374193 | LOC105374207 | LOC105374210 | LOC105374211 | LOC105374217 | LOC105374218 | LOC105374224 | LOC105374226 | LOC105374234 | LOC105374265 | LOC105374287 | LOC105374294 | LOC105374300 | LOC105374316 | LOC105374318 | LOC105374320 | LOC105374325 | LOC105374329 | LOC105374341 | LOC105374344 | LOC105374362 | LOC105374364 | LOC105374377 | LOC105374378 | LOC105374421 | LOC105374428 | LOC105374432 | LOC105374434 | LOC105374456
